You are here: Industry Insights > NICE

News List

NICE approves Wegovy™ (semaglutide) for obesity EuropeanPharmaceuticalReview
February 11, 2022
New draft guidance means thousands of obese Brits could benefit from Novo Nordisk’s Wegovy™ (semaglutide), a drug shown to improve weight loss.
NICE recommends first treatment for children with metachromatic leukodystrophy EuropeanPharmaceuticalReview
February 09, 2022
The one-time gene therapy treatment for rare, neurodegenerative disease metachromatic leukodystrophy (MLD) is the most expensive drug ever evaluated by NICE.
cancer patients miss out on innovative new treatments pharmatimes
February 07, 2022
Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes.
NICE approves lung cancer combination drug therapy for NHS use Pharmaceutical-Technology
January 14, 2022
People treated with pembrolizumab lived for 17.1 months on average versus 11.6 months for chemotherapy, trial data showed.
The NICE recommends Rinvoq for psoriatic arthritis patients pharmatimes
January 10, 2022
The chronic, inflammatory disease affects an estimated 24 in every 10,000 people.
NICE recommends MSD’s Keytruda in combination with chemotherapy for routine treatment of lung cancer pharmatimes
January 07, 2022
With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.
NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma pharmatimes
December 17, 2021
The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund.
NICE recommends osimertinib for non-small cell lung cancer (NSCLC) EuropeanPharmaceuticalReview
December 02, 2021
The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending osimertinib within the Cancer Drugs Fund (CDF).
GSK aim for HIV cure by 2030 PharmaTimes
December 01, 2021
Following its recent approval of an injectable HIV-1 treatment from the National institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hopes in developing a cure for the virus in the future...
NICE approves hormone drug which could prevent 1,200 miscarriages each year PharmaTimes
November 25, 2021
The leading UK preganancy and baby loss charity Tommy’s have said with the approval of the hormonal drug, as many as 8,450 miscarrages a year could be prevented.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 41 42 Next page